+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Head And Neck Cancer"

From
From
From
Oncologists Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Oncologists Global Market Opportunities and Strategies to 2032

  • Report
  • January 2024
  • 257 Pages
  • Global
From
From
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
From
From
From
From
From
Cancer Cachexia Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Cachexia Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
Loading Indicator

Head and neck cancer is a type of cancer that affects the head and neck region, including the mouth, throat, nose, and salivary glands. It is a subset of oncology, the branch of medicine that deals with the diagnosis and treatment of cancer. Treatment for head and neck cancer typically involves surgery, radiation therapy, and chemotherapy. Depending on the type and stage of the cancer, a combination of these treatments may be used. Head and neck cancer is a growing area of oncology, with new treatments and technologies being developed to improve outcomes for patients. Research is ongoing to better understand the causes of head and neck cancer and to develop more effective treatments. Companies in the head and neck cancer market include AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, Roche, and Sanofi. Show Less Read more